Barclays PLC Biote Corp. Transaction History
Barclays PLC
- $377 Billion
- Q3 2024
A detailed history of Barclays PLC transactions in Biote Corp. stock. As of the latest transaction made, Barclays PLC holds 77,196 shares of BTMD stock, worth $510,265. This represents 0.0% of its overall portfolio holdings.
Number of Shares
77,196
Previous 77,196
-0.0%
Holding current value
$510,265
Previous $432,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding BTMD
# of Institutions
83Shares Held
17.7MCall Options Held
0Put Options Held
0-
325 Capital LLC New York, NY4.55MShares$30.1 Million13.05% of portfolio
-
Bandera Partners LLC New York, NY2.44MShares$16.1 Million5.13% of portfolio
-
Black Rock Inc. New York, NY1.61MShares$10.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.42MShares$9.37 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.39MShares$9.21 Million0.04% of portfolio
About biote Corp.
- Ticker BTMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 7,574,270
- Market Cap $50.1M
- Description
- biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...